TherapeuticsMD Stock
TherapeuticsMD, Inc.
Company data
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Country
- United States
- CEO
- Marlan D. Walker
- Employees
- 1
- Market cap
- $22 M
- IPO
- 09/05/2007
TherapeuticsMD, Inc. is a U.S.-based pharmaceutical company dedicated to women's health. Its marketed portfolio includes IMVEXXY, prescribed for moderate to severe dyspareunia; BIJUVA, a bio-identical hormone replacement therapy combining 17ß-estradiol and progesterone, used to alleviate moderate to severe vasomotor…
TherapeuticsMD stock: price history
1D
-1.6%
1W
-7.8%
1M
-12.8%
6M
-8.2%
YTD
+16.6%
1Y
+81.0%
2Y
+20.3%
5Y
-94.7%
10Y
-99.4%
Next earnings date
Next earnings date
17/11/2026 (in 31 days)
Volatility around earnings
~21% weaker price swings than usual
Pattern chart
Pattern detected by the Market Jury detector vdouble-bottom-top-v1.0 on 13/10/26. Not a buy or sell signal.Beta
What does this mean?
Double top
BearishThe price failed at a similar high twice, with a pullback in between. This M-shaped pattern is a classic reversal signal from an uptrend into a downtrend.
Chart patterns are a purely technical signal derived from price action. At Market Jury they do not feed into the agents' buy or sell decisions, they are supplementary information only.
Ask the agents about TherapeuticsMD
Analyst assessment of TherapeuticsMD
0
STRONG BUY
4
BUY
3
HOLD
1
SELL
0
STRONG SELL
8
TOTAL · Buy
As of: 17/08/2023
TherapeuticsMD stock metrics
P/E
-101.06
P/B
0.81
EV/EBITDA
-4.63
RETURN ON EQUITY
0.6%
NET MARGIN
17.8%
DEBT/EQUITY
0.2
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
82.0%
FLOAT SHARES
9,491,787
AVG. DAILY VOLUME (30D)
17,877
Institutional holders
Dividends & Stock splits
Comparable stocks
Frequently asked questions about TherapeuticsMD stock
What does TherapeuticsMD do?
TherapeuticsMD, Inc. is a company in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry, headquartered in United States.
The CEO is Marlan D. Walker, the company employs around 1 people.
The IPO was on 09/05/2007; the stock trades on NASDAQ under the ticker TXMD.
What do analysts say about TherapeuticsMD stock?
8 analysts rate the stock, the consensus is Buy (as of 17/08/2023).
This is an external assessment, not a statement by Market Jury.
When does TherapeuticsMD report next?
The next earnings date is 17/11/2026.
Around past earnings, price swings were roughly -21% stronger than usual.
Does TherapeuticsMD pay a dividend?
No, TherapeuticsMD currently does not pay a dividend.
Which stocks are comparable to TherapeuticsMD?
Comparable stocks include Zoetis, Viatris, Lantheus Holdings, Amneal Pharmaceuticals, Indivior Pharmaceuticals, Eton Pharmaceuticals, Pacira BioSciences and Amphastar Pharmaceuticals.
How can I get TherapeuticsMD stock analyzed?
Clicking "Analyze stock" lets five strategies assess TherapeuticsMD against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.